These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 25858869)

  • 1. Procalcitonin: potential role in diagnosis and management of sepsis.
    Rowland T; Hilliard H; Barlow G
    Adv Clin Chem; 2015; 68():71-86. PubMed ID: 25858869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in the critically ill patient: procalcitonin.
    Reinhart K; Meisner M
    Crit Care Clin; 2011 Apr; 27(2):253-63. PubMed ID: 21440200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host response biomarkers in sepsis: the role of procalcitonin.
    Vincent JL; Van Nuffelen M; Lelubre C
    Methods Mol Biol; 2015; 1237():213-24. PubMed ID: 25319789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
    Harrison M; Collins CD
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.
    Albrich WC; Harbarth S
    Intensive Care Med; 2015 Oct; 41(10):1739-51. PubMed ID: 26194026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin and sepsis: recent data on diagnostic utility prognostic potential and therapeutic implications in critically ill patients.
    Kopterides P; Tsangaris I
    Minerva Anestesiol; 2012 Jul; 78(7):823-35. PubMed ID: 22561677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcomes?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2012 Sep; 60(3):370-1. PubMed ID: 22305332
    [No Abstract]   [Full Text] [Related]  

  • 9. Procalcitonin as a diagnostic and prognostic biomarker of sepsis in critically ill children.
    Leclerc F; Cremer R; Noizet O
    Pediatr Crit Care Med; 2003 Apr; 4(2):264-6. PubMed ID: 12749670
    [No Abstract]   [Full Text] [Related]  

  • 10. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
    Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
    Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin for guidance of antibiotic therapy.
    Schuetz P; Albrich W; Christ-Crain M; Chastre J; Mueller B
    Expert Rev Anti Infect Ther; 2010 May; 8(5):575-87. PubMed ID: 20455686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
    Kip MM; Kusters R; IJzerman MJ; Steuten LM
    J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interpretation of the concentrations of procalcitonin during infectious and inflammatory processes].
    Piatnitskiĭ IA; Sharandak AP; Zokina TG; Berner LP
    Ter Arkh; 2012; 84(12):120-4. PubMed ID: 23480003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
    Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
    Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators.
    Christ-Crain M; Müller B
    Eur Respir J; 2007 Sep; 30(3):556-73. PubMed ID: 17766633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
    Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
    Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of sepsis and guidance of antibiotic therapy].
    Oppert M
    Med Klin Intensivmed Notfmed; 2019 May; 114(4):286-289. PubMed ID: 30944943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin Is Not a Useful Biomarker of Sepsis.
    Talan DA
    Ann Emerg Med; 2015 Sep; 66(3):320-1. PubMed ID: 26304252
    [No Abstract]   [Full Text] [Related]  

  • 19. Can procalcitonin monitoring reduce the length of antibiotic treatment in bloodstream infections?
    Pantelidou IM; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S10-2. PubMed ID: 26686272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic biomarkers of sepsis in critical care.
    Kibe S; Adams K; Barlow G
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 2():ii33-40. PubMed ID: 21398306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.